EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as Clostridium difficile (CD) Targeted Anti-Bacterial Agent

Lijun Xie iD, Li Chen, Yongbo Wei, Nannan Chen, Tong Wu, Jingming Zhou, Hong Jiang iD, Feng Lin

Molecules · 2023

DOI: 10.3390/molecules28166152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lijun Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Clostridioides difficile. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provincial Science and Technology Special Project, Natural Science Foundation of Fujian Province, the central government for guiding and supporting local scientific and technological development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rakicidin B1 was isolated and purified from the culture broth of a marine Streptomyces sp. as a potent anti-cancer agent, and lately the compound and its derivatives have firstly been found to possess anti-Clostridium difficile (CD) activity but with high cytotoxicity. Herein, following our previous discovery on anti-CD activity of Rakicidin B1, structure modification was performed at the OH position of Rakicidin B1 and a new Rakicidin B1-PEG hybrids FIMP2 was facilely designed and synthesized by conjugating the PEG2000 with the scaffolds of Rakicidin B1 via the linkage of carbamate. The cytotoxicity of the FIMP2 was first evaluated against three different cancer cell lines, including HCT-8 cells, PANC-1, and Caco-2, with IC50 values at 0.519 μM, 0.815 μM, and 0.586 μM, respectively. Obviously, as compared with a positive control group treated with Rakicidin B1, the IC50 value of FIMP2 increased by nearly 91-fold, 50-fold, and 67-fold, suggesting that the PEGylation strategy significantly reduced the cytotoxicity of FIMP2. Thus, this preliminary result may be beneficial to increase its safety index (SI) value due to the decreased cytotoxicity of FIMP2. In addition, this decreased cytotoxicity of FIMP2 was further confirmed based on a zebrafish screening model in vivo. Thereafter, the anti-CD activity of FIMP2 was evaluated in vivo, and its efficacy to treat CDI was found to be better than that of vancomycin. The mortality and recurrence rate of FIMP2 is not as low compared with that of vancomycin; these results demonstrated that compound FIMP2 is a new, promising anti-CD agent with significant efficacy against CD recurrence with low cytotoxicity towards bodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsClostridioides difficileHumansAnimalsVancomycinCaco-2 CellsZebrafishDepsipeptidesLipopeptides

Stichwörter der Autor:innen

PEGylation strategyRakicidin B1anti-Clostridium difficilelow cytotoxicity

Substanzen

Anti-Bacterial AgentsVancomycinrakicidinsDepsipeptidesLipopeptides

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.

ORCID-Profile: Lijun Xie, Hong Jiang

Förderung

  • Provincial Science and Technology Special Project
  • Natural Science Foundation of Fujian Province
  • the central government for guiding and supporting local scientific and technological development
  • Fujian Provincial Science and Technology Special Project
  • central government

Zitieren

APA

Xie, L., Chen, L., Wei, Y., Chen, N., Wu, T., Zhou, J., Jiang, H., & Lin, F. (2023). Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as Clostridium difficile (CD) Targeted Anti-Bacterial Agent. Molecules. https://doi.org/10.3390/molecules28166152

Vancouver

Xie L, Chen L, Wei Y, Chen N, Wu T, Zhou J, et al. Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as Clostridium difficile (CD) Targeted Anti-Bacterial Agent. Molecules. 2023. doi:10.3390/molecules28166152

BibTeX
@article{Xie2023,
  author = {Xie, Lijun and Chen, Li and Wei, Yongbo and Chen, Nannan and Wu, Tong and Zhou, Jingming and Jiang, Hong and Lin, Feng},
  title = {Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as Clostridium difficile (CD) Targeted Anti-Bacterial Agent},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28166152}
}
Kostenlos starten →